Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.
anticoagulated patients
glial fibrillary acidic protein (GFAP)
minor head injury
neuron-specific enolase (NSE)
protein S100B
ubiquitin C-terminal hydrolase-L1 (UCHL-1)
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
12 Jan 2024
12 Jan 2024
Historique:
received:
18
10
2023
accepted:
26
12
2023
medline:
11
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
Data in literature indicate that in patients suffering a minor head injury (MHI), biomarkers serum levels could be effective to predict the absence of intracranial injury (ICI) on head CT scan. Use of these biomarkers in case of patients taking oral anticoagulants who experience MHI is very limited. We investigated biomarkers as predictors of ICI in anticoagulated patients managed in an ED. We conducted a single-cohort, prospective, observational study in an ED. Our structured clinical pathway included a first head CT scan, 24 h observation and a second CT scan. The outcome was delayed ICI (dICI), defined as ICI on the second CT scan after a first negative CT scan. We assessed the sensitivity (SE), specificity (SP), negative predictive value (NNV) and positive predictive value (PPV) of the biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in order to identify dICI. Our study population was of 234 patients with a negative first CT scan who underwent a second CT scan. The rate of dICI was 4.7 %. The NPV for the detection of dICI were respectively (IC 95 %): S100B 92.7 % (86.0-96.8 %,); ubiquitin C-terminal hydrolase-L1 (UCH-L1) 91.8 % (83.8-96.6 %); glial fibrillary protein (GFP) 100 % (83.2-100 %); TBI 100 % (66.4-100 %). The AUC for the detection of dICI was 0.407 for S100B, 0.563 for neuron-specific enolase (NSE), 0.510 for UCH-L1 and 0.720 for glial fibrillary acidic protein (GFAP), respectively. The NPV of the analyzed biomarkers were high and they potentially could limit the number of head CT scan for detecting dICI in anticoagulated patients suffering MHI. GFAP and Alinity TBI seem to be effective to rule out a dCI, but future trials are needed.
Identifiants
pubmed: 38206121
pii: cclm-2023-1169
doi: 10.1515/cclm-2023-1169
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Walter de Gruyter GmbH, Berlin/Boston.
Références
Garra, G, Nashed, AH, Capobianco, L. Minor head trauma in anticoagulated patients. Acad Emerg Med 1999;6:121–4. https://doi.org/10.1111/j.1553-2712.1999.tb01048.x .
doi: 10.1111/j.1553-2712.1999.tb01048.x
Li, J, Brown, J, Levine, M. Mild head injury, anticoagulants, and risk of intracranial injury. Lancet 2001;357:771–2. https://doi.org/10.1016/s0140-6736(00)04163-5 .
doi: 10.1016/s0140-6736(00)04163-5
Haydel, MJ, Preston, CA, Mills, TJ, Luber, S, Blaudeau, E, DeBlieux, PM. Indications for computed tomography in patients with minor head injury. N Engl J Med 2000;343:100–5. https://doi.org/10.1056/nejm200007133430204 .
doi: 10.1056/nejm200007133430204
Fabbri, A, Servadei, F, Marchesini, G, Dente, M, Iervese, T, Spada, M, et al.. Which type of observation for patients with high-risk mild head injury and negative computed tomography? Eur J Emerg Med 2004;11:65–9. https://doi.org/10.1097/00063110-200404000-00002 .
doi: 10.1097/00063110-200404000-00002
Menditto, VG, Lucci, M, Polonara, S, Pomponio, G, Gabrielli, A. Management of minor head injury in patients receiving oral anticoagulant therapy: a prospective study of a 24-hour observation protocol. Ann Emerg Med 2012;59:451–5. https://doi.org/10.1016/j.annemergmed.2011.12.003 .
doi: 10.1016/j.annemergmed.2011.12.003
Hadwe, SE, Assamadi, M, Barrit, S, Giannis, D, Haidich, AB, Goulis, DG, et al.. Delayed intracranial hemorrhage of patients with mild traumatic brain injury under antithrombotics on routine repeat CT scan: a systematic review and meta-analysis. Brain Inj 2022;36:703–13. https://doi.org/10.1080/02699052.2022.2065034 .
doi: 10.1080/02699052.2022.2065034
Turcato, G, Zaboli, A, Bonora, A, Ricci, G, Zannoni, M, Maccagnani, A, et al.. Analysis of clinical and laboratory risk factors of post-traumatic intracranial hemorrhage in patients on direct oral anticoagulants with mild traumatic brain injury: an observational multicenter cohort. J Emerg Med 2023;64:1–13. https://doi.org/10.1016/j.jemermed.2019.09.007 .
doi: 10.1016/j.jemermed.2019.09.007
Hier, DB, Obafemi-Ajayi, T, Thimgan, MS, Olbricht, GR, Azizi, S, Allen, B, et al.. Blood biomarkers for mild traumatic brain injury: a selective review of unresolved issues. Biomark Res 2021;9:70. https://doi.org/10.1186/s40364-021-00325-5 .
doi: 10.1186/s40364-021-00325-5
Ghaith, HS, Nawar, AA, Gabra, MD, Abdelrahman, ME, Nafady, MH, Bahbah, EI, et al.. A literature review of traumatic brain injury biomarkers. Mol Neurobiol 2022;59:4141–58. https://doi.org/10.1007/s12035-022-02822-6 .
doi: 10.1007/s12035-022-02822-6
Rogan, A, O’Sullivan, MB, Holley, A, McQuade, D, Larsen, P. Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A systemic review & meta-analysis. Injury 2022;53:259–71. https://doi.org/10.1016/j.injury.2021.10.015 .
doi: 10.1016/j.injury.2021.10.015
Mussack, T, Biberthaler, P, Kanz, KG, Heckl, U, Gruber, R, Linsenmaier, U, et al.. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock 2002;18:395–400. https://doi.org/10.1097/00024382-200211000-00002 .
doi: 10.1097/00024382-200211000-00002
Bazarian, JJ, Biberthaler, P, Welch, RD, Lewis, LM, Barzo, P, Bogner-Flatz, V, et al.. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol 2018;17:782–9. https://doi.org/10.1016/s1474-4422(18)30231-x .
doi: 10.1016/s1474-4422(18)30231-x
Welch, RD, Ayaz, SI, Lewis, LM, Unden, J, Chen, JY, Mika, VH, et al.. Ability of serum glial fibrillary acidic protein, ubiquitin C-Terminal Hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma 2016;33:203–14. https://doi.org/10.1089/neu.2015.4149 .
doi: 10.1089/neu.2015.4149
Mondello, S, Sorinola, A, Czeiter, E, Vámos, Z, Amrein, K, Synnot, A, et al.. Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis. J Neurotrauma 2021;38:1086–106. https://doi.org/10.1089/neu.2017.5182 .
doi: 10.1089/neu.2017.5182
Amoo, M, Henry, J, O’Halloran, PJ, Brennan, P, Husien, MB, Campbell, M, et al.. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy. Neurosurg Rev 2022;45:1171–93. https://doi.org/10.1007/s10143-021-01678-z .
doi: 10.1007/s10143-021-01678-z
Blais Lécuyer, J, Mercier, É, Tardif, PA, Archambault, PM, Chauny, JM, Berthelot, S, et al.. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study. Emerg Med J 2021;38:285–9. https://doi.org/10.1136/emermed-2020-209583 .
doi: 10.1136/emermed-2020-209583
Rogan, A, Sik, A, Dickinson, E, Patel, V, Peckler, B, McQuade, D, et al.. Endorsed by ACEM Emergency Department Epidemiology Network. Diagnostic performance of S100B as a rule-out test for intracranial pathology in head-injured patients presenting to the emergency department who meet NICE Head Injury Guideline criteria for CT-head scan. Emerg Med J 2023;40:159–66. https://doi.org/10.1136/emermed-2022-212549 .
doi: 10.1136/emermed-2022-212549
Skogseid, IM, Nordby, HK, Urdal, P, Paus, E, Lilleaas, F. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir 1992;115:106–11. https://doi.org/10.1007/bf01406367 .
doi: 10.1007/bf01406367
Undén, J, Ingebrigtsen, T, Romner, B, Scandinavian Neurotrauma Committee (SNC) . Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med 2013;11:50. https://doi.org/10.1186/1741-7015-11-50 .
doi: 10.1186/1741-7015-11-50
Prise en charge des patients presentant un traumatisme crânien leger de l’adulte [Management of patients suffering from mild traumatic brain injury] RPP-TCL-2022.pdf - SFMU. https://www.sfmu.org/upload/consensus/RPP-TCL-2022.pdf [Accessed 30 Jan 2023].
David, A, Mari, C, Vignaud, F, Masson, D, Planche, L, Bord, E, et al.. Evaluation of S100B blood level as a biomarker to avoid computed tomography in patients with mild head trauma under antithrombotic medication. Diagn Interv Imaging 2017;98:551–6. https://doi.org/10.1016/j.diii.2017.03.010 .
doi: 10.1016/j.diii.2017.03.010
Bossuyt, PM, Reitsma, JB, Bruns, DE, Gatsonis, CA, Glasziou, PP, Irwig, L, et al.. Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;28:h5527. https://doi.org/10.1136/bmj.h5527 .
doi: 10.1136/bmj.h5527
Baker, SP, O’Neil, B, Haddon, W, Long, WB. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187–96. https://doi.org/10.1097/00005373-197403000-00001 .
doi: 10.1097/00005373-197403000-00001
Jones, J, Clark, W, Bradford, J, Dougherty, J. Efficacy of a telephone follow-up system in the emergency department. J Emerg Med 1988;6:249–54. https://doi.org/10.1016/0736-4679(88)90336-8 .
doi: 10.1016/0736-4679(88)90336-8
Zongo, D, Ribéreau-Gayon, R, Masson, F, Laborey, M, Contrand, B, Salmi, LR, et al.. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 2012;59:209–18. https://doi.org/10.1016/j.annemergmed.2011.07.027 .
doi: 10.1016/j.annemergmed.2011.07.027
Fuller, GW, Evans, R, Preston, L, Woods, HB, Mason, S. Should adults with mild head injury who are receiving direct oral anticoagulants undergo computed tomography scanning? A systematic review. Ann Emerg Med 2019;73:66–75. https://doi.org/10.1016/j.annemergmed.2018.07.020 .
doi: 10.1016/j.annemergmed.2018.07.020
Seidenfaden, SC, Kjerulff, JL, Juul, N, Kirkegaard, H, Møller, MF, Münster, AB, et al.. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study – “the PreTBI I study”. Scand J Trauma Resuscitation Emerg Med 2021;29:75. https://doi.org/10.1186/s13049-021-00891-5 .
doi: 10.1186/s13049-021-00891-5
Gardner, RC, Puccio, AM, Korley, FK, Wang, KKW, Diaz-Arrastia, R, Okonkwo, DO, et al.. Effects of age and time since injury on traumatic brain injury blood biomarkers: a TRACK-TBI study. Brain Commun 2022;5:fcac316. https://doi.org/10.1093/braincomms/fcac316 .
doi: 10.1093/braincomms/fcac316
Ward, MD, Weber, A, Merrill, VD, Welch, RD, Bazarian, JJ, Christenson, RH. Predictive performance of traumatic brain injury biomarkers in high-risk elderly patients. J Appl Lab Med 2020;5:91–100. https://doi.org/10.1093/jalm/jfaa039 .
doi: 10.1093/jalm/jfaa039
Oris, C, Bouillon-Minois, JB, Pinguet, J, Kahouadji, S, Durif, J, Meslé, V, et al.. Predictive Performance of blood S100B in the management of patients over 65 years old with mild traumatic brain injury. J Gerontol A Biol Sci Med Sci 2021;76:1471–9. https://doi.org/10.1093/gerona/glab055 .
doi: 10.1093/gerona/glab055
Asken, BM, Elahi, FM, La Joie, R, Strom, A, Staffaroni, AM, Lindbergh, CA, et al.. Plasma Glial Fibrillary Acidic Protein levels differ along the spectra of amyloid burden and clinical disease stage. J Alzheimers Dis 2020;78:265–76. https://doi.org/10.3233/jad-200755 .
doi: 10.3233/jad-200755
Czeiter, E, Amrein, K, Gravesteijn, BY, Lecky, F, Menon, DK, Mondello, S, et al.. Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine 2020;56:102785. https://doi.org/10.1016/j.ebiom.2020.102785 .
doi: 10.1016/j.ebiom.2020.102785
Mastandrea, P, Mengozzi, S, Bernardini, S. Systematic review and cumulative meta-analysis of the diagnostic accuracy of glial fibrillary acidic protein vs. S100 calcium binding protein B as blood biomarkers in observational studies of patients with mild or moderate acute traumatic brain injury. Diagnosis 2021;9:18–27. https://doi.org/10.1515/dx-2021-0006 .
doi: 10.1515/dx-2021-0006
Richard, M, Lagares, A, Bondanese, V, de la Cruz, J, Mejan, O, Pavlov, V, et al.. BRAINI investigators. Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study. BMJ Open 2021;11:e043635. https://doi.org/10.1136/bmjopen-2020-043635 .
doi: 10.1136/bmjopen-2020-043635
Ahmadi, S, Roshdi Dizaji, S, Babahajian, A, Alizadeh, M, Sarveazad, A, Yousefifard, M. Serum glial fibrillary acidic protein in detecting intracranial injuries following minor head trauma; a systematic review and meta-analysis. Arch Acad Emerg Med 2023;11:e9. https://doi.org/10.22037/aaem.v11i1.1682 .
doi: 10.22037/aaem.v11i1.1682
DA . 510(k) Substantial equivalence determination decision summary for the Abbott Laboratories i-STAT TBI Plasma cartridge with the i-STAT Alinity System; 2021. https://www.accessdata.fda.gov/cdrh_docs/reviews/K201778.pdf [Accessed 30 Jun 2023].
Korley, FK, Datwyler, SA, Jain, S, Sun, X, Beligere, G, Chandran, R, et al.. Comparison of GFAP and UCH-L1 measurements from two prototype assays: the Abbott i-STAT and ARCHITECT assays. Neurotrauma Rep 2021;2:193–9. https://doi.org/10.1089/neur.2020.0037 .
doi: 10.1089/neur.2020.0037